ReviewDrug design, development and therapy2014
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes.
Michael A NauckPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
123 papers cite itlatest 60 shown
this paperpooled ittrialcites it